OKYO שווי כולל של נכסי החברה OKYO Pharma Inc

OKYO Pharma Limited (OKYO) business protection is based on unique patents that create significant barriers to entry for new players until the conclusion of trials. The company's success relies on regulatory approval and the proven safety of its dry eye therapy. Total assets amount to 12.33. Attracting top scientists through RSU packages confirms the price trend on the GURU.Markets platform, which visualizes the financial standing of this ophthalmology developer.

A reverse calculation via ROA makes the metric sensitive to profit generation efficiency, reflecting the actual scale of resources deployed in value creation. Total assets capture the overall value of OKYO Pharma properties, where a growing resource base should drive the long-term expansion of high-margin dry eye therapy drugs, allowing investors to assess the company's fundamental potential through total asset dynamics.